Logo

American Heart Association

  2
  0


Final ID:

Discussant: REALIZE-K

  • Zannad, Faiez  ( CVCT and Universite de Lorraine , Paris , France )
  • Allen, Larry  ( UNIVERSITY COLORADO DENVER , Aurora , Colorado , United States )
  • Author Disclosures:
    Faiez ZANNAD: DO have relevant financial relationships ; Advisor:NovoNordisk:Past (completed) ; Advisor:Northsea:Expected (by end of conference) ; Advisor:Merck:Active (exists now) ; Advisor:CEVA:Past (completed) ; Advisor:Cellprothera:Active (exists now) ; Advisor:Cereno:Active (exists now) ; Ownership Interest:CVCT:Active (exists now) ; Advisor:Cardior:Past (completed) ; Advisor:CVRx:Active (exists now) ; Advisor:BMS:Past (completed) ; Advisor:Boehringer:Active (exists now) ; Advisor:Biopeutics:Active (exists now) ; Consultant:Owkin:Active (exists now) ; Advisor:Bayer:Active (exists now) ; Advisor:Applied Therapeutics:Past (completed) | Larry Allen: DO have relevant financial relationships ; Consultant:ACI Clinical:Active (exists now) ; Researcher:PCORI:Active (exists now) ; Researcher:NIH:Active (exists now) ; Consultant:UpToDate:Active (exists now) ; Consultant:Quidel:Active (exists now) ; Consultant:Novartis:Past (completed) ; Consultant:Cytokinetics:Past (completed) ; Consultant:Boston Scientific:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Building on the 4 Pillars: Novel Trials of Medical Therapy for Heart Failure

Monday, 11/18/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
Myeloperoxidase Inhibition with Mitiperstat in Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Primary Results from the ENDEAVOR Randomized Clinical Trial

Lund Lars, Lam Carolyn, Ely Pizzato Patricia, Michaëlsson Erik, Mattsson Andrea, Ericsson Hans, Baldus Stephan, Shah Sanjiv

Discussant: The SARAH Trial

Lopez-fernandez Teresa, Ky Bonnie

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available